Efficacy of a Novel Antibacterial Agent Exeporfinium Chloride, (XF-73), Against Antibiotic-Resistant Bacteria in Mouse Superficial Skin Infection Models

Overview of attention for article published in Infection and Drug Resistance, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 2 news outlets

twitter: 7 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 1 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 11 X posts from 7 X users, with an upper bound of 3,337 followers.

RT @Sajyboy: #DEST The below is the trial done by our partner CMS in China. It is for using XF-73 in Dermal, superficial skin infections…

27 Jul 2023

Reply Repost Favourite

RT @Sajyboy: #DEST The below is the trial done by our partner CMS in China. It is for using XF-73 in Dermal, superficial skin infections…

27 Jul 2023

Reply Repost Favourite

RT @Sajyboy: #DEST The below is the trial done by our partner CMS in China. It is for using XF-73 in Dermal, superficial skin infections…

27 Jul 2023

Reply Repost Favourite

#DEST The below is the trial done by our partner CMS in China. It is for using XF-73 in Dermal, superficial skin infections. The read across from this is that I am expecting just as good results from the NIAID trial. Expecting 2 RNS. @SharePickers @My

27 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.